Plus Therapeutics, Inc.
Overview
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Their proprietary platform seeks to deliver improved outcomes through the precise delivery of radiation to tumors.
Therapeutic areas
RadiotherapeuticsOncology
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Plus Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.